- Todos > Traditional Medicine > Traditional, Complementary and Herbal Medicine
- Todos > Quality and Safety: Medicines > Quality Assurance
- Todos > Quality and Safety: Medicines > Regulatory Support
- Todos > Quality and Safety: Medicines > The International Pharmacopoeia
- Todos > WHO Prequalification of Medical Products > WHO-UNICEF-UN Project
- Palabras clave > herbal medicines
- Palabras clave > herbal products - quality, efficacy and safety
- Palabras clave > quality control
- Palabras clave > requirements and methods for quality control of finished herbal products
- Palabras clave > safety and efficacy
- Palabras clave > safety testing
- Palabras clave > traditional medicine
- Palabras clave > traditional remedies
(2017; 16 pages)
With the constant increase in the use of herbal medicines worldwide and the rapid expansion of the global market for them, the safety and quality of herbal materials and finished herbal products has become a major concern for health authorities, pharmaceutical industries and the public. The safety and efficacy of herbal medicines largely depend on their quality. Requirements and methods for quality control of finished herbal products, particularly for mixture herbal products, are far more complex than for chemical medicines. The quality of finished herbal products is also influenced by the quality of the raw materials used.
The World Health Assembly resolution on traditional medicine (WHA56.31), adopted in May 2003, requested WHO to provide technical support to develop methodology to monitor or ensure the quality, efficacy and safety of herbal products.
The International Conference of Drug Regulatory Authorities (ICDRA) in 2002 and 2004, as well as the Meetings of National Centres Participating in the WHO Programme of International Drug Monitoring (in 2000, 2001, 2002 and 2003) requested WHO to develop and continuously update the technical guidelines on quality, safety and efficacy of herbal medicines. One of the challenges in analysing the cause of adverse events reported in connection with use of herbal medicines is the lack of expertise in identifying and testing ingredients and constituents of suspect herbal products at the national pharmacovigilance centres, and/or national quality control laboratories.
To reduce the proportion of adverse events attributable to poor quality of herbal medicines, WHO has committed to developing new guidelines on quality assurance and control of herbal medicines, as well as to updating existing ones.